Skip to main content
  1. Right Decisions
  2. GGC - Clinical Guidelines
  3. Maternity
  4. Back
  5. Pregnancy losses
  6. Fetal Tissue - handling and disposal (up to and including 23+6 weeks gestation) (340)
Announcements and latest updates

Right Decision Service newsletter: October 2024

Welcome to the Right Decision Service (RDS) newsletter for October 2024.

1.Contingency arrangements for RDS outages

Development of the contingency solutions to maximise RDS resilience and minimise risk of future outages is in progress, aiming for completion by Christmas. As a reminder, these contingency arrangements  are:

  • Optimising mobile app build process
  • Mobile app always to be downloadable.
  • Serialising builds to mobile app; separate mobile app build from other editorial and end-user processes
  • Load balancing – provides failover (also enables separation of editorial processes from other processes to improve performance.)

 

In the meantime, a gentle reminder to encourage users to download essential clinical toolkits to their mobile devices so that there is an offline version always available.

 

2. New deployment with improvements.

A new scheduled deployment with minor improvements drawn from support tickets, externally funded projects, information related to outages, and feature requests will take place in early December. Key improvements planned are:

  • Deep-linking to individual toolkits within the RDS mobile app. Each toolkit will now have its own direct URL and QR code, both accessible from the app. These can be used to download the toolkit directly where users already have the RDS app installed. If the user does not yet have the RDS app installed, they will be taken to the app store to install the app and immediately afterwards the toolkit will automatically open and download. Note that this will go live a few days later than the improvements below due to the need to link up the mobile front end to the changes in the content management system.
  • Introducing an Announcement Header field to replace the hardcoded "Announcements and latest updates" text. This will enable users to see at a glance the focus of new announcements.
  • Automated daily emptying of the recycling bin (with a 30 day rolling grace period)  in the content management system. A bug preventing complete emptying of the recycling bin contributed to one of the outages earlier this year.
  • Supporting multiple passcodes (ticket 6079)
  • Expanding accordion section to show location of a search result rather than requiring user coming from a search result to manually open all sections and search again for the term.
  • Displaying first accordion section Content text as a snippet on the search results page as a fallback if default/main content is not provided
  • Displaying the context of each search result in the form of a link to the relevant parent tool/section. This will help users to choose which search result is most likely to be appropriate for their needs.
  • As part of release of the new national benzodiazepine quality prescribing guidance toolkit sponsored by Scottish Government Effective Prescribing and Therapeutics, a digital tool to support creation of benzodiazepine tapering/withdrawal schedules.

We are also seeking approval to use the NHS Scotland logo and title for the RDS app on the app stores to help with audience engagement and clarity around the provenance of RDS.

3. RDS Search, Browse and Archive/Version control enhancements

We are still hopeful that user acceptance testing for at least the Search and browse enhancements can take place before Christmas. Thank you for your patience and understanding in waiting for these improvements. Timescales have been pushed back by old app migration challenges, work to address outages, and most recently implementing the contingency arrangements.

4. Support tickets

We are aware that there continue to be some issues around a number of RDS support tickets, in part due to constraints around visibility for the RDS team of the tickets in the existing  support portal. We are investigating the potential to move to a new support ticket requesting system from early in the new year. We will organise the proposed webinar around support ticket processes once we have confirmed the way forward with the system.

Table formatting

There is a known issue with alterations in formatting of some RDS tables which seems to have arisen as a result of the 17 October deployment. Tactuum is working on a fix and on implementing additional regression testing to prevent this issue recurring.

5. New RDS toolkits

Recently launched toolkits include:

NHS Lothian Infectious Diseases

Scottish Health Technologies Group – Technology Assessment recommendations

NHS Tayside Anaesthetics and Critical Care projects – an innovative toolkit which uses PowerAutomate to manage review and response to proposals for improvement projects.

If you would like to promote one of your new toolkits through this newsletter, please contact ann.wales3@nhs.scot

A number of toolkits are expected to go live before Christmas, including:

  • Focus on dementia
  • Highland Council Getting it Right for Every Child
  • Dumfries and Galloway Adult Support and Protection procedures
  • National Waiting Well toolkit
  • Fertility Scotland National Network
  • NHS Lothian postural care for care homes

6.Sign up to RDS Editors Teams channel

We have had a good response to the recent invitation to sign up to the new Teams channel for RDS editors. This provides a forum for editors to share learning, ideas and questions and we hope to hold regular webinars on topics of interest.  The RDS team is in the process of joining participants to the channel and we’d encourage all editors to take part, using the registration form – available in Providers section of the RDS Learning and Support area.

 

7. Evaluation projects

The RDS team has worked with colleagues in NHS Grampian and the Digital Health & Care Innovation Centre to evaluate the impact of the Prevent the progress of diabetes web and mobile app in a small-scale pilot project. This app provides access to local and national resources and services targeted at people with prediabetes, a history of gestational diabetes, or candidates for remission. After just 8 weeks of using the app, 94% of patients reported increased their knowledge and understanding of diabetes, and 88% said it had increased their confidence and motivation to make lifestyle changes, highlighting specific behaviour changes. The learning from this project is informing development of a service model based on tailored support for patient groups with, high, medium and low digital self-efficacy.

Please contact ann.wales3@nhs.scot if you would like to know more about this project.

  1. Training sessions for new editors (also serve as refresher sessions for existing editors) will take place on the following dates:

  • Friday 29th November 3-4 pm
  • Thursday 5 December 3.30 -4.30 pm

To book a place, please contact Olivia.graham@nhs.scot, providing your name, organisation, job role, and level of experience with RDS editing (none, a little, moderate, extensive.)

 

To invite colleagues to sign up to receive this newsletter, please signpost them to the registration form  - also available in End-user and Provider sections of the RDS Learning and Support area.   If you have any questions about the content of this newsletter, please contact his.decisionsupport@nhs.scot  If you would prefer not to receive future newsletters, please email Olivia.graham@nhs.scot and ask to be removed from the circulation list.

With kind regards

 

Right Decision Service team

Healthcare Improvement Scotland

 

The Right Decision Service:  the national decision support platform for Scotland’s health and care

Website: https://rightdecisions.scot.nhs.uk    Mobile app download:  Apple  Android

 

 

Fetal Tissue - handling and disposal (up to and including 23+6 weeks gestation) (340)

Warning

Objectives

This document provides guidance on the handling and disposal of tissue which contains, or potentially contains, fetal tissue of up to and including 23+6 weeks gestation.

Scope

All pregnancy tissue up to and including 23+6 weeks gestation

Audience

This guideline is intended for use by healthcare professionals working within GGC.  In particular this is relevant to Pathology Department Medical and BMS Staff, Mortuary MTO Staff Obstetrics and Gynaecology, Medical, Nursing, Midwifery and theatre staff in Obstetrics and Gynaecology, Medical and Nursing Staff working in Accident and Emergency.

Please report any inaccuracies or issues with this guideline using our online form

NHS GG&C Policy on the Handling and Disposal of Fetal Tissue (up to and including 23+6 weeks gestation) 

This document is to provide guidance on the handling and disposal of tissue which contains, or potentially contains, fetal tissue of up to and including 23+6 weeks gestation. 

This includes:

  • Medical Termination of Pregnancy tissue
  • Surgical Termination of Pregnancy tissue
  • Ectopic Pregnancy tissue
  • Any tissue from an Early Pregnancy Loss (including spontaneous loss, medically managed, surgically managed and MVA)
  • Fetuses of up to and including 23+6 weeks gestation where there has been a Post Mortem Examination
  • Retained products of conception specimens

Our aim is to ensure that all fetal tissue is handled appropriately and disposed of respectfully. This has been defined as Shared Cremation with agreement of the Department of Obstetrics and Gynaecology. The purpose of this document is to provide guidance and clarity as to the appropriate examination of tissue and the paperwork which is required to allow this examination and disposal. 

Specimen Flow

Medical Termination of Pregnancy

The majority of these specimens do not require histopathological assessment. If no histopathological examination is required then the tissue should be transferred directly to the Mortuary for sensitive disposal (cremation) along with a completed copy of Authorisation for burial or cremation following pregnancy loss up to 23 weeks and 6 days gestation (Form 2).

If the tissue is to be released directly to the family then a release of pregnancy tissue form should be completed by clinical staff. If the patient opts to take the specimen from the Pathology Department then the relevant section of Form 2 should be completed and submitted with the specimen. In addition, a completed PATH-COM-COMF-006 form accepting the associated risks of taking formalin fixed tissue from the pathology department requires to be completed. Pathology staff will complete this form with the family collecting the tissue.

If there are concerns about fetal anomalies and examination is required then appropriate Post Mortem Consent should be obtained.

Any specimen received without appropriate documentation will be stored in the Pathology Department and logged as a non-conformance. The specimen will not be processed until the correct paperwork is received and may be returned to the sender. If the correct paperwork has not been received within 12 weeks, the specimen will be sampled and processed to FFPE blocks and stored in the pathology archives. No glass slides or formal histopathology report will be prepared until a completed copy of Form 2 is received by the pathology department. Following receipt of a completed copy of Form 2, a replacement request form will be required in order to generate a report on Trak Care. The remainder of the specimen will be sensitively disposed of without further examination.

NB: If a molar pregnancy is suspected clinically, accurate details of the clinical team treating the patient must be included with the request form so that if an error is identified in Form 2, the clinical team can be contacted regarding the non-conformance in a timely manner.

A Datix will be raised by Pathology if an error is made in a Form 2 that is not rectified within 4 weeks of submitting the specimen. If a Form 2 is being resubmitted, then a replacement pathology request must be made via Trak Care to generate a pathology report on Trak Care.

Surgical Termination of Pregnancy

These specimens do not require histopathological assessment. They should be transferred directly to the Mortuary for sensitive disposal (cremation) along with a completed copy of Authorisation for burial or cremation following pregnancy loss up to 23 weeks and 6 days gestation (Form 2). If the patient opts to take the specimen from the Pathology Department then the appropriate section of Authorisation for burial or cremation following pregnancy loss up to 23 weeks and 6 days gestation (Form 2) should be completed and submitted with the specimen. In addition, a completed PATHCOM-COMF-006 form accepting the associated risks of taking formalin fixed tissue from the pathology department requires to be completed. Pathology staff will complete this form with the family collecting the tissue.

Any specimen received without appropriate documentation will be stored in the Pathology Department and logged as a non-conformance. The specimen will not be processed until the correct paperwork is received and may be returned to the sender. If the correct paperwork has not been received within 12 weeks, the specimen will be sensitively disposed of without further examination.

Ectopic Pregnancy Tissue

These specimens should be sent for histopathological examination for confirmation of ectopic pregnancy and assessment of associated pathology. These specimens should be submitted to the Pathology Department with a Pathology Request form (containing relevant clinical information) and with a completed Authorisation for burial or cremation following pregnancy loss up to 23 weeks and 6 days gestation (Form 2). Following reporting, any residual tissue will be transferred from the Pathology Department to the Mortuary for sensitive disposal (cremation). If the patient opts to take the specimen from the Pathology Department then the appropriate section of Authorisation for burial or cremation following pregnancy loss up to 23 weeks and 6 days gestation (Form 2) should be completed and submitted with the specimen. In addition, a completed PATH-COM-COMF-006 form accepting the associated risks of taking formalin fixed tissue from the pathology department requires to be completed. Pathology staff will complete this form with the family collecting the tissue.

Any specimen received without appropriate documentation will be stored in the Pathology Department and logged as a non-conformance. The specimen will not be processed until the correct paperwork is received and may be returned to the sender. If the correct paperwork has not been received within 12 weeks, the specimen will placed into FFPE blocks and processed for histology. The FFPE blocks to confirm the presence of an ectopic pregnancy will remain in the pathology archives and a histopathology report will be generated when a completed copy of Form 2 is received. If this is required, a replacement specimen request form will be required to generate a report on Trak Care.

Early Pregnancy Loss Tissue

This includes spontaneously passed tissue and surgically removed tissue. It is for the sender to decide whether histopathological examination is desirable.

Possible reasons for examination include

  • Confirmation of products of conception
  • Exclusion of gestational trophoblastic disease
  • Attempts at determining cause of recurrent miscarriage

If histopathological examination is required, then the specimen should be submitted to the Pathology Department with a Pathology Request form (containing relevant clinical information) and a completed Authorisation for burial or cremation following pregnancy loss up to 23 weeks and 6 days gestation (Form 2). Following reporting, any residual tissue will be transferred from the Pathology Department to the Mortuary for sensitive disposal (cremation). If the patient opts to take the specimen from the Pathology Department then the relevant section of Authorisation for burial or cremation following pregnancy loss up to 23 weeks and 6 days gestation (Form 2) should be completed and a completed PATH-COM-COMF-006 form accepting the associated risks of taking formalin fixed tissue from the pathology department requires to be completed. Pathology staff will complete this form with the family collecting the tissue.

If no histopathological examination is required and the patient opts for the hospital to sensitively dispose of the specimen, then the specimen should be transferred directly to the Mortuary for sensitive disposal (cremation) along with a completed Form 2. If no histopathological examination irequired and the patient opts to take the tissue from the hospital the relevant section of Form 2 should also be completed to provide an audit trail for the fetal tissue as well as a completed release of pregnancy tissue form. The tissue can be passed to the patient in a suitable container. The paperwork (Form 2) should be sent to the Mortuary for registration.

Any specimen received without appropriate documentation will be stored in the Pathology Department and logged as a non-conformance. The specimen will not be processed until the correct paperwork is received and may be returned to the sender. If the correct paperwork has not been received within 12 weeks, the specimen will be sampled to FFPE block but no glass slide or formal histopathology report will be available until a completed Form 2 is received. The remainder of the specimen will be sensitively disposed of without further examination. If a histopathology report is required following receipt of the completed form 2, then a replacement pathology request will be required to generate a report on Trak Care.

NB: If a molar pregnancy is suspected clinically, accurate details of the clinical team treating the patient must be included with the request form so that if an error is identified in Form 2, the clinical team can be contacted regarding the non-conformance in a timely manner. A Datix will be raised by Pathology if an error is made in a Form 2 that is not rectified within 4 weeks of submitting the specimen. If a Form 2 is being resubmitted, then a replacement pathology request must be made via Trak Care to generate a pathology report on Trak Care.

Recurrent Miscarriage or Suspected Underlying Cytogenetic Cause of Pregnancy Loss

RCOG Guidelines (GT17) recommend that cytogenetic analysis of the products of conception should be performed for all couples with a history of recurrent miscarriage, (loss of three or more pregnancies).

Previously this required division of tissue for both histological and cytogenetic analysis. With the centralization of laboratory services this is no longer necessary. Products of conception should be sent complete to Cytogenetics (in a dry sterile container – not in formalin) with the relevant request form giving a clear history and a completed Form 2. Please ensure that the sample container itself is also labelled with appropriate patient identifiers. Following examination within both Cytogenetics and Pathology, any residual tissue will be transferred from the Pathology Department to the Mortuary for sensitive disposal (cremation). The same applies to the examination of fetal and placental tissues where an underlying cytogenetic cause is suspected e.g. following detection of abnormality on early ultrasound scan or miscarriage associated with raised risk of aneuploidy on antenatal screening.

Fetuses up to and including 23+6 weeks gestation where there is to be a Post Mortem Examination

These specimens should be transferred directly to the mortuary along with any associated placental tissue and appropriately completed Post Mortem Consent Forms. The further handling of these requests is detailed elsewhere.

Retained Products of Conception Specimens in which there has been a separately identified fetus

This clinical scenario has been previously discussed at the Sensitive Disposal Committee. It has been agreed that there is no requirement to supply a Form 2. Surplus tissue will be disposed of as clinical waste.

Tissue Type

Tissue Flow

Sample and Paperwork Required

Medical Termination of Pregnancy tissue

Histopathology assessment not required and tissue for shared cremation/sensitive disposal

  • pathology/tissue specimen dry specimen -completed Form 2

Send to the mortuary, QEUH

Medical Termination of Pregnancy tissue

If specimen does not require Histopathology assessment and being released to family without further assessment

  • pathology/tissue specimen dry
  • completed Form 2 – send to pathology for registration -release of pregnancy tissue form
  • Tissue to be sent with parent

Medical Termination of Pregnancy tissue

If specimen requires histopathology assessment

  • pathology/tissue specimen in formalin
  • completed Form 2
  • pathology request form

Send to the pathology department, QEUH *

Medical Termination of Pregnancy tissue

If specimen requires cytogenetic and histopathology assessment

  • pathology/tissue specimen in sterile dry pot
  • completed Form 2
  • pathology request form
  • cytogenetics request form

Send to the Cytogenetics department, QEUH*

Medical Termination of Pregnancy tissue

If specimen requires postmortem assessment

  • pathology/tissue/fetal specimen
  • completed Form 2
  • pathology request form (for placenta)
  • completed PM authorisation form

Send fetus and placenta as dry sample to mortuary

Send to the pathology department, QEUH*

Surgical Termination of Pregnancy tissue

Histopathology assessment not required

  • pathology/tissue specimen dry specimen -completed Form 2

Send to the mortuary, QEUH*

Surgical Termination of Pregnancy tissue

If specimen requires histopathology assessment

  • pathology/tissue specimen in formalin
  • completed Form 2
  • pathology request form

Send to the pathology department, QEUH*

If suspected molar pregnancy please ensure clear documentation of lead clinician and contact details

Surgical Termination of Pregnancy tissue

If specimen requires cytogenetic and histopathology assessment

  • pathology/tissue specimen in dry sterile pot
  • completed Form 2
  • pathology request form
  • cytogenetic request form

Send to the Cytogenetics department, QEUH*

Ectopic Pregnancy tissue

Histopathology required

  • pathology specimen in formalin
  • completed Form 2
  • pathology request form

Send to Pathology Department, QEUH*

Tissue from an Early Pregnancy Loss (pregnancy loss up to 11+6 weeks gestation)

Histopathology required

  • pathology/tissue specimen in formalin
  • completed Form 2
  • pathology request form

Send to Pathology Department, QEUH *

Tissue from an Early Pregnancy Loss (pregnancy loss up to 11+6 weeks gestation)

Histopathology NOT required

  • pathology specimen (dry ) -completed Form 2

Send to the Mortuary, QEUH

Tissue after recurrent miscarriage (3 consecutive early losses)

Tissue for histopathology and cytogenetics

  • pathology specimen in dry sterile container -pathology request
  • cytogenetics request -completed Form 2

Send to Cytogenetics department QEUH*

Fetus of between 11 and 23+6 weeks gestation where there is a Post Mortem Examination (postmortem requests for less than 11 weeks gestation MUST be discussed with a pathologist)

Histopathology and Post

Mortem Examination required

  • pathology/tissue/fetal specimen
  • completed Form 2
  • pathology request form (for placenta)
  • completed PM authorisation form

Send fetus and placenta as dry sample to mortuary

Send to the mortuary department, QEUH*

Retained products of conception (RPOC) specimen in which there has been a separately identified fetus.

Histopathology required

  • Pathology/tissue specimen in formalin
  • Pathology request to confirm RPOC
  • No need for Form 2 for RPOC component

Send to Pathology Department QEUH*

Retained products of conception (RPOC) specimen with NO separately identified fetus

Histopathology required

  • Pathology/tissue specimen in formalin
  • Pathology request to confirm RPOC
  • Completed Form 2

Send to Pathology department QEUH*

*if parents want to take tissue home from mortuary following cytogenetics and histopathology, they will require to have a Form PATH-COM-COMF-006 completed at the time of collection from pathology. This form makes them aware of the risks of handling tissue that has been stored in formalin. Pathology staff will complete the form with the family collecting the tissue. Photographic Identification is required for collection of tissue. Please make the family aware that there may not be any tissue remaining after examination.

Editorial Information

Last reviewed: 14/06/2022

Next review date: 14/07/2025

Author(s): Dr Felicity Watson, Claire Higgins.

Version: 3

Approved By: Gynaecology Clinical Governance Group

Document Id: 340